Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)

Dabigatran versus warfarin in patients with atrial fibrillation

Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430

Apixaban versus warfarin in patients with atrial fibrillation

Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552

Guidelines for the management of atrial fibrillation

Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,954

Edoxaban versus warfarin in patients with atrial fibrillation

Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

(1999) · The Lancet · doi:10.1016/s0140-6736(99)04440-2 · Cited by 5,141

Shared decision-making in the medical encounter: what does it mean? (Or it takes at least two to tango)

Charles, C., Gafni, A., & Whelan, T. (1997) · Social Science & Medicine · doi:10.1016/s0277-9536(96)00221-3 · Cited by 4,137 · cited 1×

Mild cognitive impairment

Gauthier, S. G., Reisberg, ‌., Zaudig, M., Petersen, R. C., Ritchie, K. A., Broich, K., Belleville, S., Brodaty, H., Bennett, D. A., Chertkow, H. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 4,094

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,823

The Seattle Heart Failure Model

Levy, W. C., Mozaffarian, D., Linker, D. T., Sutradhar, S., Anker, S. D., Cropp, A. B., Anand, I. S., Maggioni, A. P., Burton, P. B. J., Sullivan, M. D., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.584102 · Cited by 2,024

The Framingham Study

Dawber, T. R. (1980) · Harvard University Press eBooks · doi:10.4159/harvard.9780674492097 · Cited by 1,965

Guidelines for the management of atrial fibrillation

Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · EP Europace · doi:10.1093/europace/euq350 · Cited by 1,764

Stroke Severity in Atrial Fibrillation

Lin, H., Wolf, P. A., Kelly‐Hayes, M., Beiser, A., Kase, C. S., Benjamin, E. J., & D’Agostino, R. B. (1996) · Stroke · doi:10.1161/01.str.27.10.1760 · Cited by 1,412

Multidisciplinary strategies for the management of heart failure patients at high risk for admission

McAlister, F. A., Stewart, S., Ferrua, S., & McMurray, J. J. V. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.05.055 · Cited by 1,343

Mild Cognitive Impairment

Petersen, R. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp0910237 · Cited by 1,289

Treatment of Supraventricular Tachycardia Due to Atrioventricular Nodal Reentry by Radiofrequency Catheter Ablation of Slow-Pathway Conduction

Jackman, W. M., Beckman, K. J., McClelland, J. H., Wang, X., Friday, K. J., Roman, C. A., MOULTON, K. P., Twidale, N., Hazlitt, H. A., PRIOR, M. I., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207303270504 · Cited by 1,156

More ‘Malignant’ Than Cancer? Five-Year Survival Following a First Admission for Heart Failure

Stewart, S., Macintyre, K., Hole, D. J., Capewell, S., & McMurray, J. J. V. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00141-0 · Cited by 1,064

Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation

Hylek, E. M., Evans‐Molina, C., Shea, C., Henault, L. E., & Regan, S. (2007) · Circulation · doi:10.1161/circulationaha.106.653048 · Cited by 1,063

Untitled work

Blomstrom-Lundqvist (2003) · doi:10.1161/01.cir.0000091380.04100.84 · Cited by 955

Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial

Kück, K., Schaumann, A., Eckardt, L., Willems, S., Ventura, R., Delacrétaz, E., Pitschner, H.-F., Kautzner, J., Schumacher, B., & HANSEN, P. S. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61755-4 · Cited by 808

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Moss, A. J., Myerburg, R. J., et al. (2006) · EP Europace · doi:10.1093/europace/eul108 · Cited by 741

Diagnosis and Cure of the Wolff–Parkinson–White Syndrome or Paroxysmal Supraventricular Tachycardias during a Single Electrophysiologic Test

Calkins, H. G., de Sousa, J., El-Atassi, R., Rosenheck, S., de Buitleir, M., Kou, W. H., Kadish, A. H., Langberg, J. J., & Morady, F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106063242302 · Cited by 698

Quality of life in patients with atrial fibrillation: a systematic review

Thrall, G., Lane, D., Carroll, D., & Lip, G. Y. H. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.057 · Cited by 697

2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation

Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., & Kirchhof, P. F. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.11.003 · Cited by 687

ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias∗∗This document does not cover atrial fibrillation; atrial fibrillation is covered in the ACC/AHA/ESC guidelines on the management of patients with atrial fibrillation found on the ACC, AHA, and ESC Web sites.—executive summary

Blomström‐Lundqvist, C., Scheinman, M. M., Aliot, E., Alpert, J. S., Calkins, H. G., Camm, A. J., Campbell, W. B., Haines, D. E., Kück, K., Lerman, B. B., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.013 · Cited by 684

Relationship between burden of premature ventricular complexes and left ventricular function

Baman, T. S., Lange, D. C., Ilg, K. J., Gupta, S. K., Liu, T.-Y., Alguire, C., Armstrong, W., Good, E., Chugh, A., Jongnarangsin, K., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.03.036 · Cited by 676

Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century

Ball, J., Carrington, M. J., McMurray, J. J. V., & Stewart, S. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.093 · Cited by 652

Explaining risks: turning numerical data into meaningful pictures

Edwards, A., Elwyn, G. J., & Mulley, A. G. (2002) · BMJ · doi:10.1136/bmj.324.7341.827 · Cited by 645

Long-Term Follow-up of Asymptomatic Healthy Subjects with Frequent and Complex Ventricular Ectopy

Kennedy, H. L., Whitlock, J. A., Sprague, M. K., Kennedy, L. J., Buckingham, T. A., & Goldberg, R. J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501243120401 · Cited by 628

Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes

Priori, S. G., Wilde, A. A. M., Horie, M., Cho, Y., Behr, E. R., Berul, C. I., Blom, N. A., Brugada, J., Chiang, C., Huikuri, H. V., et al. (2013) · EP Europace · doi:10.1093/europace/eut272 · Cited by 626

Quality of Life in the Antiarrhythmics Versus Implantable Defibrillators Trial: Impact of Therapy and Influence of Adverse Symptoms and Defibrillator Shocks

Schron, E. B., Exner, D. V., Yao, Q., Jenkins, L. S., Steinberg, J. S., Cook, J. R., Kutalek, S. P., Friedman, P. L., Bubien, R. S., Page, R. L., et al. (2002) · Circulation · doi:10.1161/hc0502.103330 · Cited by 624

2010 Focused Update of ESC Guidelines on device therapy in heart failure

Authors Task Force Members, Dickstein, K., Vardas, P. E., Auricchio, A., Daubert, J., Linde, C. M., McMurray, J. J. V., Ponikowski, P. P., Priori, S. G., Sutton, R., et al. (2010) · EP Europace · doi:10.1093/europace/euq392 · Cited by 593

Corrigendum to: ‘Guidelines for the management of atrial fibrillation’ [European Heart Journal (2010) 31, 2369–2429 and EP-Europace (2010) 12, 1360–1420]

Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., Prendergast, B., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq512 · Cited by 555

A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953–1989

Munger, T. M., Packer, D. L., Hammill, S. C., Feldman, B. J., Bailey, K. R., Ballard, D. J., Holmes, D. R., & Gersh, B. J. (1993) · Circulation · doi:10.1161/01.cir.87.3.866 · Cited by 500

Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin

Apostolakis, S. Z., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2013) · CHEST Journal · doi:10.1378/chest.13-0054 · Cited by 480

Drugs and Brugada syndrome patients: Review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)

Postema, P. G., Wolpert, C., Amin, A. S., Probst, V., Borggrefe, M. M., Roden, D. M., Priori, S. G., Tan, H. L., Hiraoka, M., Brugada, J., et al. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.07.002 · Cited by 411

Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation

Hendriks, J. M. L., de Wit, R., Crijns, H. J. G. M., Vrijhoef, H. J. M., Prins, M. H., Pisters, R., Pison, L. A. F. G., Blaauw, Y., & Tieleman, R. G. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs071 · Cited by 409

Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)

Mont, L., Bisbal, F., Hernández-Madrid, A., Pérez-Castellano, N., Viñolas, X., Arenal, A., Arribas, F., Fernández-Lozano, I., Bodegas, A., Cobos, A., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht457 · Cited by 394

EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy

Padeletti, L., Arnar, D. O., Boncinelli, L., Brachman, J., Camm, A. J., Daubert, J., Kassam, S., Deliëns, L., Glikson, M., Hayes, D. L., et al. (2010) · EP Europace · doi:10.1093/europace/euq275 · Cited by 382

PACES/HRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern

Cohen, M. I., Triedman, J. K., Cannon, B. C., Davis, A. M., Drago, F., Janoušek, J., Klein, G. J., Law, I. H., Morady, F., Paul, T., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.03.050 · Cited by 379

Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data

Heneghan, C. J., Ward, A. M., Perera, R., Bankhead, C. R., Fuller, A., Stevens, R., Bradford, K., Tyndel, S., Alonso‐Coello, P., Ansell, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61294-4 · Cited by 373

Vitamin K antagonists in heart disease: Current status and perspectives (Section III)

Husted, S., Wallentin, L. C., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S. D., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0443 · Cited by 373

Parenteral anticoagulants in heart disease: Current status and perspectives (Section II)

Husted, S., Wallentin, L. C., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S. D., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0403 · Cited by 366

Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy

Knecht, S., Oelschläger, C., Duning, T., Lohmann, H., Albers, J., Stehling, C., Heindel, W. L., Breithardt, G., Berger, K., Ringelstein, E. B., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn341 · Cited by 356

Risk Stratification of Individuals with the Brugada Electrocardiogram: A Meta‐Analysis

Gehi, A. K., Duong, T. D., Metz, L. D., Gomes, J. A., & Mehta, D. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00455.x · Cited by 332

EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion

Meier, B., Blaauw, Y., Khattab, A. A., Lewalter, T., Sievert, H., Tondo, C., Glikson, M., ESC Scientific Document Group, Lip, G. Y. H., López-Mínguez, J. R., et al. (2014) · EP Europace · doi:10.1093/europace/euu174 · Cited by 330

Management of Implantable Cardioverter Defibrillators in End-of-Life Care

Goldstein, N. E., Lampert, R., Bradley, E., Lynn, J., & Krumholz, H. M. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-11-200412070-00006 · Cited by 325

A Taxonomy for Disease Management

Krumholz, H. M., Currie, P. M., Riegel, B. J., Phillips, C. O., Peterson, E. D., Smith, R., Yancy, C. W., & Faxon, D. P. (2006) · Circulation · doi:10.1161/circulationaha.106.177322 · Cited by 310

Prediction of Mode of Death in Heart Failure

Mozaffarian, D., Anker, S. D., Anand, I. S., Linker, D. T., Sullivan, M. D., Cleland, J. G. F., Carson, P. E., Maggioni, A. P., Mann, D. L., Pitt, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.687103 · Cited by 305

Depression, Anxiety, and Quality of Life in Patients With Atrial Fibrillation

Thrall, G., Lip, G. Y. H., Carroll, D., & Lane, D. A. (2007) · CHEST Journal · doi:10.1378/chest.07-0036 · Cited by 303

Cardiology Patient Page

Ornato, J. P., & Hand, M. M. (2001) · Circulation · doi:10.1161/01.cir.103.25.e124 · Cited by 294

Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias

Bubien, R. S., Knotts-Dolson, S. M., Plumb, V. J., & Kay, G. N. (1996) · Circulation · doi:10.1161/01.cir.94.7.1585 · Cited by 284

Atrial Fibrillation Is Associated with Severe Acute Ischemic Stroke

Dulli, D. A., Stanko, H., & Levine, R. L. (2003) · Neuroepidemiology · doi:10.1159/000068743 · Cited by 277

Aborted sudden death in the Wolff-Parkinson-White syndrome

Timmermans, C., Smeets, J. L. R. M., Rodriguez, L.-M., Vrouchos, G., van den Dool, A., & Wellens, H. J. J. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80136-2 · Cited by 274

A Patient Decision Aid Regarding Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation A Randomized Controlled Trial

Man‐Son‐Hing, M. (1999) · JAMA · doi:10.1001/jama.282.8.737 · Cited by 271

Meta-analysis of ablation of atrial flutter and supraventricular tachycardia

Spector, P., Reynolds, M. R., Calkins, H., Sondhi, M., Xu, Y., Martin, A., Williams, C. J., & Sledge, I. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.040 · Cited by 268

The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: A systematic review

Magyar-Russell, G., Thombs, B. D., Cai, J. X., Baveja, T., Kuhl, E. A., Singh, P. P., Montenegro Braga Barroso, M., Arthurs, E., Roseman, M., Amin, N., et al. (2011) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2011.02.014 · Cited by 267

Prognostic Implications of Asymptomatic Ventricular Arrhythmias: The Framingham Heart Study

Bikkina, M., Larson, M. G., & Levy, D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-990 · Cited by 266

Patient Values and Preferences in Decision Making for Antithrombotic Therapy: A Systematic Review

MacLean, S., Mulla, S. M., Akl, E. A., Jankowski, M., Vandvik, P. O., Ebrahim, S., McLeod, S. L., Bhatnagar, N., & Guyatt, G. H. (2012) · CHEST Journal · doi:10.1378/chest.11-2290 · Cited by 252

Silent Cerebral Infarction in Patients With Nonrheumatic Atrial Fibrillation

Ezekowitz, M. D., James, K. E., Nazarian, S. M., Davenport, J., Broderick, J. P., Gupta, S. R., Thadani, V. M., Meyer, M., & Bridgers, S. L. (1995) · Circulation · doi:10.1161/01.cir.92.8.2178 · Cited by 250

Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure

Packer, D. L., Prutkin, J. M., Hellkamp, A. S., Mitchell, L. B., Bernstein, R. C., Wood, F., BOEHMER, J. P., Carlson, M. D., Frantz, R. P., McNulty, S. E., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.853689 · Cited by 243

Symptoms Experienced in the Last Six Months of Life in Patients with End-Stage Heart Failure

Nordgren, L., & Sörensen, S. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00059-8 · Cited by 243

What Works In Chronic Care Management: The Case Of Heart Failure

Sochalski, J. A., Jaarsma, T., Krumholz, H. M., Laramee, A. S., McMurray, J. J. V., Naylor, M. D., Rich, M. W., Riegel, B. J., & Stewart, S. (2009) · Health Affairs · doi:10.1377/hlthaff.28.1.179 · Cited by 241

How Well Do Doctors Know their Patients? Factors Affecting Physician Understanding of Patients’ Health Beliefs

Street, R. L., & Haidet, P. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1453-3 · Cited by 237

Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?

Gallagher, A. M., Rietbrock, S., Plumb, J., & van Staa, T. P. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03059.x · Cited by 232

Relationship Between Patients’ Warfarin Knowledge and Anticoagulation Control

Tang, E. O. Y., Lai, C. S., Lee, K. K., Wong, R. S. M., Cheng, G. Y.-M., & Chan, T. Y. K. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1a198 · Cited by 232

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

Lip, G. Y. H., Andreotti, F., Fauchier, L., Huber, K., Hylek, E. M., Knight, E., Lane, D. A., Levi, M. M., Marín, F. R., Palareti, G., et al. (2011) · EP Europace · doi:10.1093/europace/eur126 · Cited by 224

Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population

Levy, W. C., Lee, K. L., Hellkamp, A. S., Poole, J. E., Mozaffarian, D., Linker, D. T., Maggioni, A. P., Anand, I. S., Poole-Wilson, P. A., Fishbein, D. P., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.816884 · Cited by 221

Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial

Clarkesmith, D. E., Pattison, H. M., Lip, G. Y. H., & Lane, D. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074037 · Cited by 209

Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: The Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study

Reynolds, M. R., Lavelle, T. A., Essebag, V., Cohen, D. J., & ZIMETBAUM, P. J. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.08.011 · Cited by 192

Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis

Guerra, F., Shkoza, M., Scappini, L., Flori, M., & Capucci, A. (2013) · EP Europace · doi:10.1093/europace/eut304 · Cited by 182

“Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia”

Navarese, E. P., Lupi, A., Buffon, A., & Luca, G. D. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.10.011 · Cited by 179

Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: Effects of an educational intervention programme

Lane, D. A., Ponsford, J., Shelley, A., Sirpal, A., & Lip, G. Y. H. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.07.031 · Cited by 177

Treating patients with ventricular ectopic beats

Ng, G. A. (2006) · Heart · doi:10.1136/hrt.2005.067843 · Cited by 176

Evaluation of patients with palpitations

Zimetbaum, P., & Josephson, M. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805073381907 · Cited by 172

“That’s Like an Act of Suicide” Patients’ Attitudes Toward Deactivation of Implantable Defibrillators

Goldstein, N. E., Mehta, D., Siddiqui, S. A., Teitelbaum, E. N., Zeidman, J. A., Singson, M., Pe, E., Bradley, E. H., & Morrison, R. S. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0239-8 · Cited by 172

Functional Status in Rate- Versus Rhythm-Control Strategies for Atrial Fibrillation

Chung, M. K., Shemanski, L. R., Sherman, D. G., Greene, H. L., Hogan, D. B., Kellen, J. C., Kim, S. G., Martin, L. W., Rosenberg, Y., & Wyse, D. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.040 · Cited by 171

Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation

Howitt, A. J., & Armstrong, D. (1999) · BMJ · doi:10.1136/bmj.318.7194.1324 · Cited by 169

Ethnic Differences in Patient Perceptions of Atrial Fibrillation and Anticoagulation Therapy: The West Birmingham Atrial Fibrillation Project

Lip, G. Y. H., Kamath, S., Jafri, M., Mohammed, A., & Bareford, D. (2002) · Stroke · doi:10.1161/hs0102.101817 · Cited by 168

Academic Physicians Use Placebos in Clinical Practice and Believe in the Mind–Body Connection

Sherman, R. E., & Hickner, J. M. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0332-z · Cited by 164

Unrecognized Paroxysmal Supraventricular Tachycardia: Potential for Misdiagnosis as Panic Disorder

Lessmeier, T. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440260085013 · Cited by 157

Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation

Clarkesmith, D., Pattison, H. M., Khaing, P., & Lane, D. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008600.pub3 · Cited by 152

Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial

Stewart, S., Ball, J., Horowitz, J. D., Marwick, T. H., Mahadevan, G., Wong, C., Abhayaratna, W. P., Chan, Y. K., Esterman, A., Thompson, D. R., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61992-9 · Cited by 147

Patients with supraventricular tachycardia presenting with aborted sudden death: Incidence, mechanism and long-term follow-up

Wang, Y., Scheinman, M. M., Chien, W. W., Cohen, T. J., Lesh, M. D., & Griffin, J. C. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90508-7 · Cited by 146

Safety and efficacy of well managed warfarin

Sjögren, V., Grzymala-Lubanski, B., Renlund, H., Friberg, L., Lip, G. Y. H., Svensson, P. J., & Själander, A. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-10-0859 · Cited by 145

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

Kirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., Bailleul, C., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., et al. (2013) · Europace · doi:10.1093/europace/eut232 · Cited by 141

A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial

Thomson, R. G., Eccles, M., Steen, I. N., Greenaway, J., Stobbart, L., Murtagh, M., & May, C. R. (2007) · BMJ Quality & Safety · doi:10.1136/qshc.2006.018481 · Cited by 139

Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators

Brigadeau, F., Kouakam, C., Klug, D., Marquié, C., Duhamel, A., Mizon-Gérard, F., Lacroix, D., & Kacet, S. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi726 · Cited by 136

Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation

Ansell, J., Jacobson, A. K., Levy, J., Völler, H., & Hasenkam, J. M. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.11.008 · Cited by 135

Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers

Hein, H., Panhuyzen-Goedkoop, N., Corrado, D., Hoffmann, E., Biffi, A., Delise, P., Blomstrom-Lundqvist, C., Vanhees, L., IvarHoff, P., Dorwarth, U., et al. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000216543.54066.72 · Cited by 134

Epidemiologic Features of Asymptomatic Cerebral Infarction in Patients With Nonvalvular Atrial Fibrillation

Feinberg, W. M. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390220082016 · Cited by 130

Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation

Regpala, S., Lacombe, S., Sharma, M., Gibbens, S., Ball, D., Francis, K., & LaHaye, S. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-05-0424 · Cited by 130

Electrical Storm in Patients with an Implanted Defibrillator: A Matter of Definition

Israel, C. W., & Barold, S. S. (2007) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2007.00187.x · Cited by 127

Understanding risk and lessons for clinical risk communication about treatment preferences

Edwards, A., & Elwyn, G. J. (2001) · BMJ Quality & Safety · doi:10.1136/qhc.0100009 · Cited by 125

A Systematic Review of Depression and Anxiety in Patients with Atrial Fibrillation: The Mind-Heart Link

Patel, D., Mc Conkey, N. D., Sohaney, R., Mc Neil, A., Jedrzejczyk, A., & Armaganijan, L. (2013) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2013/159850 · Cited by 124

Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

O'Brien, E. C., Simon, D. N., Allen, L. A., Singer, D. E., Fonarow, G. C., Kowey, P. R., Thomas, L. E., Ezekowitz, M. D., Mahaffey, K. W., Chang, P., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.07.002 · Cited by 121

An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality

Aliot, E., Breithardt, G., Brugada, J., Camm, J., Lip, G. Y. H., Vardas, P. E., Wagner, M., & for the Atrial Fibrillation AWareness And Risk Education (AF AWARE) group [comprising the Atrial Fibrillation Association (AFA), T. E. H. R. A. (. (2010) · Europace · doi:10.1093/europace/euq109 · Cited by 119

Occurrence of Frequent Complex Arrhythmias Detected by Ambulatory Monitoring

Glasser, S. P., Clark, P. I., & Applebaum, H. J. (1979) · CHEST Journal · doi:10.1378/chest.75.5.565 · Cited by 118

Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management

Braunschweig, F., Boriani, G., Bauer, A., Hatala, R., Herrmann‐Lingen, C., Kautzner, J., Pedersen, S. S., Pehrson, S. M., Ricci, R. P., & Schalij, M. J. (2010) · EP Europace · doi:10.1093/europace/euq316 · Cited by 116

Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation

Lane, D. A., Langman, C. M., Lip, G. Y. H., & Nouwen, A. (2009) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.10.007 · Cited by 113

Quality of Life and Functional Capacity in Patients With Atrial Fibrillation and Congestive Heart Failure

Horduna, I., Roy, D., Frasure‐Smith, N., Talajic, M. R., Lespérance, F., Blondeau, L., Dorian, P., & Khairy, P. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.031 · Cited by 111

Psychological Distress in Patients Diagnosed With Atrial Fibrillation

McCabe, P. J. (2010) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e3181b7be36 · Cited by 111

Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs

Bathina, M., Mickelsen, S., Brooks, C., Jaramillo, J., Hepton, T., & Kusumoto, F. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00416-0 · Cited by 109

Shared Decision Making in Atrial Fibrillation

Seaburg, L., Hess, E. P., Coylewright, M. J., Ting, H. H., McLeod, C. J., & Montori, V. M. (2014) · Circulation · doi:10.1161/circulationaha.113.004498 · Cited by 109

Living With Atrial Fibrillation

McCabe, P. J., Schumacher, K. L., & Barnason, S. A. (2011) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e31820019b9 · Cited by 109

Frequency of disabling symptoms in supraventricular tachycardia

Wood, K. A., Drew, B. J., & Scheinman, M. M. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00701-1 · Cited by 104

Knowledge and self-management behaviors of patients with recently detected atrial fibrillation

McCabe, P. J., Schad, S., Hampton, A., & Holland, D. E. (2008) · Heart & Lung · doi:10.1016/j.hrtlng.2007.02.006 · Cited by 104

Cost-effectiveness of a specialized atrial fibrillation clinic vs. usual care in patients with atrial fibrillation

Hendriks, J., Tomini, F., van Asselt, T., Crijns, H., & Vrijhoef, H. (2013) · Europace · doi:10.1093/europace/eut055 · Cited by 100

Usefulness of Ventricular Premature Complexes to Predict Coronary Heart Disease Events and Mortality (from the Atherosclerosis Risk In Communities Cohort)

Massing, M. W., Simpson, R. J., Rautaharju, P. M., Schreiner, P. J., Crow, R. S., & HEISS, G. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.06.061 · Cited by 98

The Effect of Anxiety and Depression on Symptoms Attributed to Atrial Fibrillation

THOMPSON, T. S., Barksdale, D. J., Sears, S. F., Mounsey, J. P., Pursell, I. W., & Gehi, A. K. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12292 · Cited by 96

The prognostic significance of premature ventricular complexes in adults without clinically apparent heart disease: a meta-analysis and systematic review

Lee, V., Hemingway, H., Harb, R., Crake, T., & Lambiase, P. D. (2012) · Heart · doi:10.1136/heartjnl-2012-302005 · Cited by 92

Preferences of patients with heart failure for prognosis communication

Caldwell, P., Arthur, H. M., & Demers, C. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70829-2 · Cited by 91

Ventricular Arrhythmias and Risk of Death and Acute Myocardial Infarction in Apparently Healthy Subjects of Age ≥55 Years

Sajadieh, A., Nielsen, O. W., Rasmussen, V., Hein, H. O., Frederiksen, B. S., Davanlou, M., & Hansen, J. F. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.067 · Cited by 91

Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial

Walfridsson, H., Walfridsson, U., Nielsen, J. C., Johannessen, A. C., Raatikainen, P. M. J., Janzon, M., Levin, L., Aronsson, M., Hindricks, G., Kongstad, O., et al. (2015) · EP Europace · doi:10.1093/europace/euu342 · Cited by 90

Patient and Cardiologist Perceptions on Decision Making for Implantable Cardioverter‐Defibrillators: A Qualitative Study

Matlock, D. D., Nowels, C. T., Masoudi, F. A., Sauer, W. H., Bekelman, D. B., Main, D. S., & Kutner, J. S. (2011) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2011.03237.x · Cited by 87

Significant gender-related differences in radiofrequency catheter ablation therapy

Dagres, N., Clague, J. R., BREITHARDT, G. E., & Borggrefe, M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00925-2 · Cited by 86

Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease

Ingles, J., Sarina, T., Kasparian, N. A., & Semsarian, C. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.006 · Cited by 86

Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review

Udompanich, S., Lip, G. Y. H., Apostolakis, S. Z., & Lane, D. A. (2013) · QJM · doi:10.1093/qjmed/hct129 · Cited by 83

The Hemodynamic Mechanism of Pounding in the Neck in Atrioventricular Nodal Reentrant Tachycardia

Gürsoy, S., Steurer, G., Brugada, J., Andries, E., & Brugada, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209103271105 · Cited by 83

Psychopathology and Symptoms of Atrial Fibrillation: Implications for Therapy

Gehi, A. K., Sears, S. F., GOLI, N. M., Walker, J., Chung, E. H., Schwartz, J., Wood, K., Guise, K. D., & Mounsey, J. P. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02264.x · Cited by 82

Safe drug use in long QT syndrome and Brugada syndrome: comparison of website statistics

Postema, P. G., Neville, J., de Jong, J. S. S. G., Romero, K., Wilde, A. A. M., & Woosley, R. L. (2013) · EP Europace · doi:10.1093/europace/eut018 · Cited by 80

Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial

Holbrook, A. M., Labiris, R., Goldsmith, C. H., Ota, K., Harb, S. C., & Sebaldt, R. J. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060837 · Cited by 79

Health-Related Quality of Life in Patients Newly Diagnosed with Atrial Fibrillation

Kang, Y., & Bahler, R. C. (2004) · European Journal of Cardiovascular Nursing · doi:10.1016/j.ejcnurse.2003.12.002 · Cited by 78

Psychological Correlates of Quality of Life in Atrial Fibrillation

Ong, L., Cribbie, R. A., Harris, L., Dorian, P., Newman, D., Mangat, I., Nolan, R. P., & Irvine, J. (2006) · Quality of Life Research · doi:10.1007/s11136-006-0029-5 · Cited by 77

Pre implantation psychological functioning preserved in majority of implantable cardioverter defibrillator patients 12months post implantation

Pedersen, S. S., Hoogwegt, M. T., Jordaens, L. J. L. M., & Theuns, D. A. M. J. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.10.092 · Cited by 75

General anxiety, depression, and physical health in relation to symptoms of heart-focused anxiety- a cross sectional study among patients living with the risk of serious arrhythmias and sudden cardiac death

Hamang, A., Eide, G. E., Rokne, B., Nordin, K., & Øyen, N. (2011) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-9-100 · Cited by 75

Dilated cardiomyopathy in children with ventricular preexcitation: the location of the accessory pathway is predictive of this association

ten Cate, F. E. A. U., Kruessell, M. A., Wagner, K., Trieschmann, U., Emmel, M., Brockmeier, K., & Sreeram, N. (2009) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2009.09.007 · Cited by 74

Does ICD Indication Affect Quality of Life and Levels of Distress?

Pedersen, S. S., Sears, S. F., Burg, M. M., & van den Broek, K. C. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.02196.x · Cited by 73

Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients

Thylén, I., Dekker, R. L., Jaarsma, T., Strömberg, A., & Moser, D. K. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.05.007 · Cited by 73

Relation of Atrial and/or Ventricular Premature Complexes on a Two-Minute Rhythm Strip to the Risk of Sudden Cardiac Death (the Atherosclerosis Risk in Communities [ARIC] Study)

Cheriyath, P., He, F., Ian Peters, B., Li, X., Alagona, P., Wu, C., Pu, M., Cascio, W. E., & Liao, D. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.09.002 · Cited by 71

Quality of life and depression in patients with different patterns of atrial fibrillation.

Dąbrowski, R., Bąk, E. S., Kowalik, I., Kazimierska, B., Wójcicka, M., & Szwed, H. (2010) · PubMed · Cited by 70

Understanding atrial symptom reports: objective versus subjective predictors

SEARS, S. F., SERBER, E. R., ALVAREZ, L. G., SCHWARTZMAN, D. S., HOYT, R. H., & UJHELYI, M. R. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00171.x · Cited by 70

Outcomes after radiofrequency catheter ablation of atrial tachycardia

Anguera, I., Brugada, J., Roba, M., Mont, L., Aguinaga, L., Geelen, P., & Brugada, P. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01531-9 · Cited by 70

Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice

Stelfox, H. T. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.09.010 · Cited by 68

Patients' Experiences of Being a Burden on Family in Terminal Illness

Johnson, J. O., Sulmasy, D. P., & Nolan, M. T. (2007) · Journal of Hospice and Palliative Nursing · doi:10.1097/01.njh.0000289656.91880.f2 · Cited by 67

The atrial fibrillation knowledge scale: Development, validation and results

Hendriks, J., Crijns, H. J. G. M., Tieleman, R. G., & Vrijhoef, H. J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.047 · Cited by 67

Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy)

Goldberg, A. S., Bathina, M. N., Mickelsen, S., Nawman, R., West, G., & Kusumoto, F. M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02285-3 · Cited by 67

Patients’ experiences from symptom onset to initial treatment for atrial fibrillation

McCabe, P. J., Rhudy, L. M., & DeVon, H. A. (2014) · Journal of Clinical Nursing · doi:10.1111/jocn.12708 · Cited by 66

Predictors and Prognostic Implications of Incident Heart Failure Following the First Diagnosis of Atrial Fibrillation in Patients with Structurally Normal Hearts: the Belgrade Atrial Fibrillation Study

Potpara, T., Polovina, M. M., Licina, M. M., Marinković, J., & Lip, G. Y. H. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft004 · Cited by 65

Development and validation of a new Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA) with focus on symptom burden

Walfridsson, U., Årestedt, K., & Strömberg, A. (2012) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-10-44 · Cited by 65

Best Practice for Atrial Fibrillation Patient Education

Lane, D. A., Barker, R., & Lip, G. Y. H. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140825125715 · Cited by 65

Shock as a Determinant of Poor Patient‐Centered Outcomes in Implantable Cardioverter Defibrillator Patients: Is There More to It Than Meets the Eye?

PEDERSEN, S. S., VAN DEN BROEK, K. C., VAN DEN BERG, M., & THEUNS, D. A. M. J. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02845.x · Cited by 63

Depression in paroxysmal and persistent atrial fibrillation patients: a cross-sectional comparison of patients enroled in two large clinical trials†

Rothe, A. V. E., Goette, A., Kirchhof, P. F., Breithardt, G., Limbourg, T., Calvert, M., Baumert, J., & Ladwig, K. (2013) · EP Europace · doi:10.1093/europace/eut361 · Cited by 63

Avoidance hierarchies and preferences for anticoagulation--semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin

Fuller, R. (2004) · Age and Ageing · doi:10.1093/ageing/afh202 · Cited by 63

Risk communication and older people--understanding of probability and risk information by medical inpatients aged 75 years and older

Fuller, R. C. (2001) · Age and Ageing · doi:10.1093/ageing/30.6.473 · Cited by 62

Supraventricular tachycardia and the struggle to be believed

Wood, K. A., Wiener, C. L., & Kayser-Jones, J. (2007) · European Journal of Cardiovascular Nursing · doi:10.1016/j.ejcnurse.2007.02.006 · Cited by 60

Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation

Clarkesmith, D., Pattison, H. M., & Lane, D. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008600.pub2 · Cited by 60

Adolescents with Implantable Cardioverter Defibrillators: A Patient and Parent Perspective

Rahman, B., Macciocca, I., Sahhar, M., Kamberi, S., Connell, V., & Duncan, R. E. (2011) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2011.03229.x · Cited by 57

The effect of beta‐blocker therapy on quality of life in heart failure patients: a systematic review and meta‐analysis

Dobre, D., van Jaarsveld, C. H. M., DeJongste, M. J. L., Ruskamp, F. M. H., & Ranchor, A. V. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1234 · Cited by 54

Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation

Tan, E. S., Rienstra, M., Wiesfeld, A. C. P., SCHOONDERWOERD, B. A., Hobbel, H. H. F., & Gelder, I. C. V. (2008) · EP Europace · doi:10.1093/europace/eun020 · Cited by 54

Illness Beliefs in Patients with Recurrent Symptomatic Atrial Fibrillation

McCabe, P. J., Barnason, S. A., & Houfek, J. F. (2011) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2011.03105.x · Cited by 52

Features and Outcomes of Patients Who Underwent Cardiac Device Deactivation

Buchhalter, L. C., Ottenberg, A. L., Webster, T. L., Swetz, K. M., Hayes, D. L., & Mueller, P. S. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.11564 · Cited by 52

Patients' Perspective on Deactivation of the Implantable Cardioverter-Defibrillator Near the End of Life

Pedersen, S. S., Chaitsing, R., Szili‐Törok, T., Jordaens, L. J. L. M., & Theuns, D. A. M. J. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.296 · Cited by 51

Catheter Ablation of Ventricular Tachycardia

Tung, R. H., Boyle, N. G., & Shivkumar, K. (2010) · Circulation · doi:10.1161/circulationaha.110.963371 · Cited by 50

Patient experiences with atrial fibrillation and treatment with implantable atrial defibrillation therapy

Deaton, C., Dunbar, S. B., Moloney, M. F., Sears, S. F., & Ujhelyi, M. R. (2003) · Heart & Lung · doi:10.1016/s0147-9563(03)00074-8 · Cited by 49

Oral anticoagulation in atrial fibrillation: A pan-European patient survey

Lip, G. Y. H., Agnelli, G., Thach, A. A., Knight, E., Rost, D., & Tangelder, M. J. D. (2007) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2006.11.005 · Cited by 49

Severe left ventricular dysfunction in infants with ventricular preexcitation

Cadrin‐Tourigny, J., Fournier, A., Andelfinger, G., & Khairy, P. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.05.022 · Cited by 48

Increased Anxiety in Partners of Patients with a Cardioverter‐Defibrillator: The Role of Indication for ICD Therapy, Shocks, and Personality

Pedersen, S. S., van den Berg, M., Erdman, R. A. M., van Son, J., Jordaens, L. J. L. M., & Theuns, D. A. M. J. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.02201.x · Cited by 48

Predictors of Psychosocial Adjustment in Patients with Implantable Cardioverter Defibrillators

Burgess, E. S., Quigley, J. F., MORAN, G., SUTTON, F. J., & GOODMAN, M. (1997) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1997.tb03568.x · Cited by 47

Patients’ well-being: experience and actions in their preventing and handling of atrial fibrillation

Ekblad, H., Rönning, H., Fridlund, B., & Malm, D. (2012) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515112457132 · Cited by 47

Current trends in supraventricular tachycardia management.

Sohinki, D., & OBEL, O. A. (2014) · PubMed Central · Cited by 45

PTSD and Automatic Implantable Cardioverter Defibrillators

Hamner, M. B., Hunt, N., Gee, J., Garrell, R., & Monroe, R. R. (1999) · Psychosomatics · doi:10.1016/s0033-3182(99)71277-6 · Cited by 44

Prevalence and Importance of Comorbidities in Patients With Heart Failure

Triposkiadis, F. K., & Skoularigis, J. S. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0110-z · Cited by 43

Psychological indices and phantom shocks in patients with ICD

Prudente, L. A., Reigle, J., Bourguignon, C. M., Haines, D. E., & Dimarco, J. (2006) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-006-9010-z · Cited by 43

Subjectively Reported Symptoms in Patients with Persistent Atrial Fibrillation and Emotional Distress

Kupper, N. H. M., van den Broek, K. C., Widdershoven, J. W. M. G., & Denollet, J. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2013.00192 · Cited by 43

TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)

Smith, D. E., Xuereb, C. B., Pattison, H. M., Lip, G. Y., & Lane, D. A. (2010) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-10-21 · Cited by 42 · cited 1×

Patient perception of symptoms and quality of life following ablation in patients with supraventricular tachycardia

Wood, K. A., Stewart, A. L., Drew, B. J., Scheinman, M. M., & Froëlicher, E. S. (2010) · Heart & Lung · doi:10.1016/j.hrtlng.2009.04.001 · Cited by 42

An integrated chronic care program for patients with atrial fibrillation

Hendriks, J. M. L., de Wit, R., Vrijhoef, H. J. M., Tieleman, R. G., & Crijns, H. J. G. M. (2010) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2009.12.017 · Cited by 41

Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making

Eckman, M. H., Wise, R. E., Naylor, K., Arduser, L., Lip, G. Y. H., D, B. M. K. M., Flaherty, M. L., Kleindorfer, D., Khan, F., Schauer, D. P., et al. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1019608 · Cited by 41

Predictors of electrical storm recurrences in patients with implantable cardioverter-defibrillators

Streitner, F., Kuschyk, J., Veltmann, C., Mahl, E., Dietrich, C., Schimpf, R., Doesch, C., Streitner, I., Wolpert, C., & Borggrefe, M. (2010) · EP Europace · doi:10.1093/europace/euq428 · Cited by 41

Advance Health Planning and Treatment Preferences among Recipients of Implantable Cardioverter Defibrillators: An Exploratory Study

Berger, J. T., Gorski, M., & Cohen, T. J. (2006) · The Journal of Clinical Ethics · doi:10.1086/jce200617109 · Cited by 40

Patient knowledge of atrial fibrillation: 3‐month follow‐up after an emergency room visit

Koponen, L., Rekola, L., Ruotsalainen, T., Lehto, M., Leino‐Kilpi, H., & Voipio‐Pulkki, L. (2007) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2007.04465.x · Cited by 40

Patient Perspectives of Dabigatran: Analysis of Online Discussion Forums

Vaughan‐Sarrazin, M., Cram, P. M., Mazur, A., Ward, M., & Reisinger, H. S. (2013) · Patient · doi:10.1007/s40271-013-0027-y · Cited by 39

Effect of Left Atrial Ablation on the Quality of Life in Patients With Atrial Fibrillation

Miyazaki, S., Kuwahara, T., Takahashi, A., Kobori, A., Takahashi, Y., Nozato, T., Hikita, H., Sato, A., Aonuma, K., Hirao, K., et al. (2007) · Circulation Journal · doi:10.1253/circj.72.582 · Cited by 39

The impact of supraventricular tachycardias on driving ability in patients referred for radiofrequency catheter ablation

WALFRIDSSON, U., & WALFRIDSSON, H. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.09753.x · Cited by 39

What patients want and need to know about atrial fibrillation

McCabe, P. J. (2011) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s19315 · Cited by 38

Sustained high quality of life in a 5-year long term follow-up after successful ablation for supra-ventricular tachycardia. results from a large retrospective patient cohort

Meissner, A., Stifoudi, I., Weismüller, P., Schrage, M.-O., Maagh, P., Christ, M., Butz, T., Trappe, H.-J., & Plehn, G. (2009) · International Journal of Medical Sciences · doi:10.7150/ijms.6.28 · Cited by 37

Anxiety disorders in patients with implantable cardioverter defibrillators: Frequency, course, predictors, and patients' requests for treatment

LANG, S., BECKER, R., WILKE, S., HARTMANN, M., HERZOG, W., & LÖWE, B. (2014) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12276 · Cited by 36

Catheter Ablation of Ventricular Tachycardia

Tung, R. H., Boyle, N. G., & Shivkumar, K. (2011) · Circulation · doi:10.1161/circulationaha.110.989079 · Cited by 36

Effect of Anxiety and Depression on the Recurrence of Paroxysmal Atrial Fibrillation After Circumferential Pulmonary Vein Ablation

Yu, S., Zhao, Q., Wu, P., Qin, M., Huang, H., Cui, H., & Huang, C. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2012.02436.x · Cited by 35

Wolff‐Parkinson‐White Syndrome and Atrioventricular Nodal Re‐Entry Tachycardia in a Swedish Population: Consequences on Health‐Related Quality of Life

Walfridsson, U., Strömberg, A., Janzon, M., & Walfridsson, H. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02476.x · Cited by 35

Quality of Life Issues in Patients With Implantable Cardioverter Defibrillators

Shea, J. B. (2004) · AACN Clinical Issues Advanced Practice in Acute & Critical Care · doi:10.1097/00044067-200407000-00013 · Cited by 34

Comorbidity burden is associated with poor psychological well-being and physical health status in patients with an implantable cardioverter-defibrillator

Hoogwegt, M. T., Kupper, N. H. M., Jordaens, L. J. L. M., Pedersen, S. S., & Theuns, D. A. M. J. (2013) · EP Europace · doi:10.1093/europace/eut072 · Cited by 34

Exploring barriers to optimal anticoagulation for atrial fibrillation: interviews with clinicians

Decker, C., Garavalia, Garavalia, B., Simon, 。., Spertus, J. A., Loeb, & Daniel, W. C. (2012) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s33045 · Cited by 33

Quality of life in pediatric patients affected by electrophysiologic disease

Czosek, R. J., Cassedy, A. E., Wray, J., Wernovsky, G., Newburger, J. W., Mussatto, K. A., Mahony, L., Tanel, R. E., Cohen, M. I., Franklin, R. C. G., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.01.022 · Cited by 32

The impact of the implantable cardioverter defibrillator on quality of life

Gallagher, R., McKinley, S., Mangan, B., Pelletier, D., Squire, J., & Mitten‐Lewis, S. (1997) · American Journal of Critical Care · doi:10.4037/ajcc1997.6.1.16 · Cited by 32

Development and initial psychometric evaluation of the Patient Perspective of Arrhythmia Questionnaire

Wood, K. A., Stewart, A. L., Drew, B. J., Scheinman, M. M., & Frolicher, E. S. (2009) · Research in Nursing & Health · doi:10.1002/nur.20347 · Cited by 31

Current strategy for treatment of patients with Wolff-Parkinson-White syndrome and asymptomatic preexcitation in Europe: European Heart Rhythm Association survey

Svendsen, J. H., Dagres, N., Dobreanu, D., Bongiorni, M. G., Marinskis, G., & Blomström‐Lundqvist, C. (2013) · EP Europace · doi:10.1093/europace/eut094 · Cited by 31

Antiarrhythmic Drug Use in Patients <65 Years With Atrial Fibrillation and Without Structural Heart Disease

LaPointe, N. M. A., Dai, D., Thomas, L. E., Piccini, J. P., Peterson, E. D., & Al‐Khatib, S. M. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.11.005 · Cited by 31

Practical Management: A Systematic Approach to the Evaluation of Exercise-Related Syncope in Athletes

O’Connor, F. G., Levine, B. D., Childress, M. A., Asplundh, C. A., & Oriscello, R. G. (2009) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0b013e3181b732c3 · Cited by 30

Impairment of driving abilities in patients with supraventricular tachycardias

Dhala, A., Bremner, S., Blanck, Z., Sra, J., Deshpande, S., Jazayeri, M. R., & Akhtar, M. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80595-5 · Cited by 29

Shock and Patient Preimplantation Type D Personality Are Associated With Poor Health Status in Patients With Implantable Cardioverter-Defibrillator

Pedersen, S. S., Tekle, F. B., Hoogwegt, M. T., Jordaens, L. J. L. M., & Theuns, D. A. M. J. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.964197 · Cited by 28

Relation of Symptomatic Heart Failure and Psychological Status to Persistent Depression in Patients With Implantable Cardioverter-Defibrillator

Pedersen, S. S., Hoogwegt, M. T., Jordaens, L. J. L. M., & Theuns, D. A. M. J. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.02.344 · Cited by 28

Deactivation of implantable cardioverter-defibrillators: results of patient surveys

Heřman, D., Štros, P., Čurila, K., Kebza, V., & Osmancik, P. P. (2013) · EP Europace · doi:10.1093/europace/eus432 · Cited by 28

Quality of life before and after radiofrequency catheter ablation in patients with drug refractory atrioventricular nodal reentrant tachycardia

Larson, M. S., McDonald, K., Young, C., Sung, R., & Hlatky, M. A. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00338-0 · Cited by 27

Incidence and predictors of phantom shocks in implantable cardioverter defibrillator recipients

Kraaier, K., Starrenburg, A., Verheggen, R. M., van der Palen, J. A. M., & SCHOLTEN, M. F. (2012) · Netherlands Heart Journal · doi:10.1007/s12471-012-0345-z · Cited by 26

Effect of Uncertainty on Depression in Patients With Newly Diagnosed Atrial Fibrillation

Kang, Y. (2006) · Progress in Cardiovascular Nursing · doi:10.1111/j.0889-7204.2006.04810.x · Cited by 25

Phantom shocks in patients with implantable cardioverter defibrillator: results from a randomized rehabilitation trial (COPE-ICD)

Berg, S. K., Moons, P., Zwisler, A., Winkel, P., Pedersen, B. D., Pedersen, P. U., & Svendsen, J. H. (2013) · EP Europace · doi:10.1093/europace/eut087 · Cited by 25

Quality of life improvement after radiofrequency catheter ablation of outfl ow tract ventricular arrhythmias in patients with structurally normal hearts

Pytkowski, M., Maciąg, A., Jankowska, A., Kowalik, I., Kraska, A., Farkowski, M. M., Golicki, D., & Szwed, H. (2012) · Acta cardiologica. Supplementum · doi:10.1080/ac.67.2.2154205 · Cited by 24

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418

2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Zeppenfeld, K., Tfelt‐Hansen, J., Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,432

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123

Cardiac tachyarrhythmias and patient values and preferences for their management: The European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS)

Lane, D. A., Aguinaga, L., Blomstrom-Lundqvist, C., Boriani, G., Dan, G.-A., Hills, M., Hylek, E. M., LaHaye, S. A., Lip, G. Y. H., Lobban, T., et al. (2015) · Research Bank (Australian Catholic University)

Device-detected subclinical atrial tachyarrhythmias: definition, implications and management—an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

Görenek, B., Bax, J. J., Boriani, G., Chen, S., Dagres, N., Glotzer, T. V., Healey, J. S., Israel, C. W., Kudaiberdieva, G., Levin, L., et al. (2017) · EP Europace · doi:10.1093/europace/eux163 · Cited by 249

Treatment of ventricular arrhythmias by United States cardiologists: a survey before the cardiac arrhythmia suppression trial results were available

Morganroth, J., Bigger, J. T., & Anderson, J. L. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90023-t · Cited by 50

Troubles du rythme cardiaque

Horvilleur, J., & Lacotte, J. (2004) · EMC - Médecine · doi:10.1016/j.emcmed.2004.03.003 · Cited by 3

Abstract session 13: devices-tachycardia I: optimal patient selection

(2004) · Heart Rhythm · doi:10.1016/j.hrthm.2004.03.013